GeneReach Biotechnology Stock Forecast - Triple Exponential Smoothing

4171 Stock  TWD 26.75  0.50  1.83%   
The Triple Exponential Smoothing forecasted value of GeneReach Biotechnology on the next trading day is expected to be 26.62 with a mean absolute deviation of 0.27 and the sum of the absolute errors of 15.94. GeneReach Stock Forecast is based on your current time horizon.
  
Triple exponential smoothing for GeneReach Biotechnology - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When GeneReach Biotechnology prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in GeneReach Biotechnology price movement. However, neither of these exponential smoothing models address any seasonality of GeneReach Biotechnology.

GeneReach Biotechnology Triple Exponential Smoothing Price Forecast For the 14th of December 2024

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of GeneReach Biotechnology on the next trading day is expected to be 26.62 with a mean absolute deviation of 0.27, mean absolute percentage error of 0.13, and the sum of the absolute errors of 15.94.
Please note that although there have been many attempts to predict GeneReach Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that GeneReach Biotechnology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

GeneReach Biotechnology Stock Forecast Pattern

Backtest GeneReach BiotechnologyGeneReach Biotechnology Price PredictionBuy or Sell Advice 

GeneReach Biotechnology Forecasted Value

In the context of forecasting GeneReach Biotechnology's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. GeneReach Biotechnology's downside and upside margins for the forecasting period are 25.46 and 27.78, respectively. We have considered GeneReach Biotechnology's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
26.75
26.62
Expected Value
27.78
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of GeneReach Biotechnology stock data series using in forecasting. Note that when a statistical model is used to represent GeneReach Biotechnology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors -0.0206
MADMean absolute deviation0.2702
MAPEMean absolute percentage error0.0092
SAESum of the absolute errors15.939
As with simple exponential smoothing, in triple exponential smoothing models past GeneReach Biotechnology observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older GeneReach Biotechnology observations.

Predictive Modules for GeneReach Biotechnology

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as GeneReach Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
26.0927.2528.41
Details
Intrinsic
Valuation
LowRealHigh
24.5333.5934.75
Details
Bollinger
Band Projection (param)
LowMiddleHigh
27.8228.7129.60
Details

Other Forecasting Options for GeneReach Biotechnology

For every potential investor in GeneReach, whether a beginner or expert, GeneReach Biotechnology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. GeneReach Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in GeneReach. Basic forecasting techniques help filter out the noise by identifying GeneReach Biotechnology's price trends.

GeneReach Biotechnology Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GeneReach Biotechnology stock to make a market-neutral strategy. Peer analysis of GeneReach Biotechnology could also be used in its relative valuation, which is a method of valuing GeneReach Biotechnology by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

GeneReach Biotechnology Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of GeneReach Biotechnology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of GeneReach Biotechnology's current price.

GeneReach Biotechnology Market Strength Events

Market strength indicators help investors to evaluate how GeneReach Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GeneReach Biotechnology shares will generate the highest return on investment. By undertsting and applying GeneReach Biotechnology stock market strength indicators, traders can identify GeneReach Biotechnology entry and exit signals to maximize returns.

GeneReach Biotechnology Risk Indicators

The analysis of GeneReach Biotechnology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in GeneReach Biotechnology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting genereach stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with GeneReach Biotechnology

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if GeneReach Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneReach Biotechnology will appreciate offsetting losses from the drop in the long position's value.

Moving together with GeneReach Stock

  0.764743 Oneness BiotechPairCorr
  0.856547 Medigen Vaccine BiologicsPairCorr
  0.94174 OBI PharmaPairCorr

Moving against GeneReach Stock

  0.780050 YuantaP shares TaiwanPairCorr
  0.740057 Fubon MSCI TaiwanPairCorr
  0.630053 YuantaP shares TaiwanPairCorr
  0.592609 Yang Ming MarinePairCorr
  0.564162 PharmaEnginePairCorr
The ability to find closely correlated positions to GeneReach Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GeneReach Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GeneReach Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GeneReach Biotechnology to buy it.
The correlation of GeneReach Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GeneReach Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GeneReach Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for GeneReach Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for GeneReach Stock Analysis

When running GeneReach Biotechnology's price analysis, check to measure GeneReach Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneReach Biotechnology is operating at the current time. Most of GeneReach Biotechnology's value examination focuses on studying past and present price action to predict the probability of GeneReach Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneReach Biotechnology's price. Additionally, you may evaluate how the addition of GeneReach Biotechnology to your portfolios can decrease your overall portfolio volatility.